Ageing society boosts Europe’s joint health market, Frost & Sullivan finds

By Kavitha Sivasubramaniam contact

- Last updated on GMT

Related tags: Frost & Sullivan, Joint health, Ageing

Ageing society boosts joint health market, Frost & Sullivan finds
An ageing society, along with a growing wish for a healthy lifestyle, is boosting the bone and joint health ingredients market in Europe, a report by Frost & Sullivan suggests.

The new Global Bone and Joint Health Ingredients Industry analysis found that the increasing need for clinically validated and natural ingredients is also supporting the sector’s development.

Increasing demand

According to the business consultancy firm, the prevalence of bone and joint health-related diseases have risen due to sedentary lifestyle and an ageing society. It predicts that the worldwide bone and joint health ingredients market is likely to soar from $3.73 billion (£3.12 billion) in 2021 to $6.01 billion (£5.02 billion) by 2030, equating to a compound yearly growth rate (CAGR) of 5.4%.

Akheela Dhiman, Chemicals, Materials & Nutrition Industry Analyst at Frost & Sullivan, says: “The growing awareness and desire for a healthy lifestyle, enhanced by the COVID-19 pandemic, has led to an increased demand for value-added and nutritious food and beverages and an increased spending on these products.

“Formulators have shown significant interest in incorporating clinically proven ingredients with fewer side effects, encouraging ingredient suppliers to innovate and offer science-backed ingredients, such as curcumin and natural eggshell membrane.”

Growth opportunities

Frost & Sullivan says demand is increasing for bone and joint health ingredients among a number of end-use industries, which present lucrative opportunities. It advises businesses in the market to consider investing in R&D of clinically backed, natural ingredients and urges manufacturers to concentrate on creating ingredients to address bone, tendons, muscles and joints conditions simultaneously because of rising consumer awareness of the need to maintaining their general mobility.

The company also believes that manufacturers should offer highly bioavailable forms of bone and joint health ingredients with increased stability, enhanced efficacy, and greater formulation benefits.

Dhiman adds: “Ingredients such as curcumin, vitamin K, collagen peptide, and magnesium will grow the fastest during the forecast period.

“More clinical studies highlighting these ingredients’ significance in maintaining bone health will drive adoption. Furthermore, ongoing deep research in developing combination solutions using formulation knowledge and unique technology further drives the industry growth.”

The newest addition to Frost & Sullivan’s Chemicals, Materials & Nutrition research and analysis, Global Bone and Joint Health Ingredients Growth Opportunities can be accessed through the Frost & Sullivan Leadership Council.

Related news

Related products

Omega-3 & MenaQ7® K2: A Dynamic Duo

Omega-3 & MenaQ7® K2: A Dynamic Duo

Gnosis by Lesaffre USA | 15-Sep-2022 | Infographic

Omega-3 and Vitamin K2 as MK-7 have compelling health claims with validated mechanisms of action for the heart. But by balancing Calcium metabolism, K2...

Improve DOMS and Postexercise Lactate Accumulation

Improve DOMS and Postexercise Lactate Accumulation

Gencor-Pacific | 08-Sep-2022 | Clinical Study

Hydrocurc®’s clinical study suggests that a highly bioavailable curcumin may facilitate a quicker return to exercise training and/or allow a higher training...

Stronger Bones Begin with MenaQ7® Vitamin K2

Stronger Bones Begin with MenaQ7® Vitamin K2

Gnosis by Lesaffre | 06-Jun-2022 | Infographic

By activating the K-dependent protein Osteocalcin, Vitamin K2 as MK-7 enables the body to properly utilize calcium, binding it to the bone matrix.

Related suppliers

Follow us

Products

View more

Webinars